AFT Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NZSE:AFT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Nov 24	BuyNZ$126	Hartley Atkinson	Individual	45	NZ$2.80
25 Nov 24	BuyNZ$28,112	Hartley Atkinson	Individual	10,087	NZ$2.79
22 Nov 24	BuyNZ$257,498	Andrew Lane	Individual	95,000	NZ$2.71
06 Nov 24	BuyNZ$3,642,093	Accident Compensation Corporation, Asset Management Arm	Company	1,261,636	NZ$2.89
06 Nov 24	SellNZ$272,000	Accident Compensation Corporation, Asset Management Arm	Company	80,000	NZ$3.40
14 May 24	BuyNZ$2,995,247	Accident Compensation Corporation, Asset Management Arm	Company	1,152,018	NZ$2.60

Insider Trading Volume

Insider Buying: AFT insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AFT?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	2,880,769	2.75%
Institutions	8,191,723	7.81%
General Public	20,970,633	20%
Individual Insiders	72,823,135	69.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 12 shareholders own 80% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
68.7%	Hartley Atkinson	72,041,741	NZ$201.7m	0.01%	no data
7.17%	Accident Compensation Corporation, Asset Management Arm	7,523,033	NZ$21.1m	18.6%	0.43%
1.89%	Apex Group Ltd.	1,986,638	NZ$5.6m	0%	no data
0.83%	Hama Holdings Limited	867,826	NZ$2.4m	0%	no data
0.47%	Salt Investment Funds Limited	492,694	NZ$1.4m	54.1%	2.14%
0.27%	Joeri Sels	286,325	NZ$801.7k	0%	no data
0.21%	Jon Lamb	221,305	NZ$619.7k	0%	no data
0.17%	David Flacks	178,764	NZ$500.5k	0%	no data
0.12%	Dimensional Fund Advisors LP	129,996	NZ$364.0k	0%	no data
0.091%	Andrew Lane	95,000	NZ$266.0k	0%	no data
0.044%	FCA Corp	46,000	NZ$128.8k	0%	0.02%
0.025%	Rivers Leigh Limited	26,305	NZ$73.6k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 06:38
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AFT Pharmaceuticals Limited is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
John Hester	Bell Potter
Jack Crowley	Credit Suisse
Soo Romanoff	Edison Investment Research